Zobrazeno 1 - 10
of 94
pro vyhledávání: '"COVID-19 mRNA vaccines"'
Autor:
Maurizio Federico
Publikováno v:
Vaccines, Vol 12, Iss 11, p 1281 (2024)
The action of mRNA-based vaccines requires the expression of the antigen in cells targeted by lipid nanoparticle–mRNA complexes. When the vaccine antigen is not fully retained by the producer cells, its local and systemic diffusion can have consequ
Externí odkaz:
https://doaj.org/article/116b214b47fa4b52918b227ddef3d55f
Autor:
Sreemanee Raaj Dorajoo, Hui Xing Tan, Chun Hwee Desmond Teo, Jing Wei Neo, Yen Ling Koon, Jing Jing Amelia Ng, Mun Yee Tham, Pei Qin Belinda Foo, Li Fung Peck, Pei San Ang, Theen Adena Lim, Wang Woon Jalene Poh, Su Lin Dorothy Toh, Cheng Leng Chan, Ian Douglas, Bee Leng Sally Soh
Publikováno v:
Vaccine: X, Vol 15, Iss , Pp 100419- (2023)
Background: The real-world safety profile of COVID-19 mRNA vaccines remains incompletely elucidated. Methods: We performed a nationwide post-market safety surveillance analysis in Singapore, on vacinees aged 5 years and older, through mid-September 2
Externí odkaz:
https://doaj.org/article/788d3d4e63034c6a810a1a442f5c4d0a
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Mariko Mouri, Mitsuru Imamura, Shotaro Suzuki, Tatsuya Kawasaki, Yoshiki Ishizaki, Keiichi Sakurai, Hiroko Nagafuchi, Norihiro Matsumura, Marina Uchida, Takayasu Ando, Kohei Yoshioka, Seido Ooka, Takahiko Sugihara, Hiroshi Miyoshi, Masaaki Mori, Tomoyuki Okada, Masao Yamaguchi, Hiroyuki Kunishima, Motohiro Kato, Kimito Kawahata
Publikováno v:
Allergology International, Vol 71, Iss 4, Pp 512-519 (2022)
Background: The mechanism of allergic reactions to COVID-19 mRNA vaccines has not been clarified. Polyethylene glycol (PEG) is a potential antigen in the components of vaccines. However, there is little evidence that allergy after COVID-19 mRNA vacci
Externí odkaz:
https://doaj.org/article/487d8d69a5f24176855c9716279742e8
Publikováno v:
Health Science Reports, Vol 5, Iss 6, Pp n/a-n/a (2022)
Abstract Background and Aims Vaccine response is a concern in hemodialysis patients. Given that hemodialysis patients were not included in clinical trials, we aimed to synthesize the available evidence on the immunogenicity of coronavirus disease 201
Externí odkaz:
https://doaj.org/article/76fa688e38de4bc0a6b1a1cbaeb17cd4
Publikováno v:
Vaccines, Vol 11, Iss 4, p 747 (2023)
Each injection of any known vaccine results in a strong expression of pro-inflammatory cytokines. This is the result of the innate immune system activation, without which no adaptive response to the injection of vaccines is possible. Unfortunately, t
Externí odkaz:
https://doaj.org/article/1caa08276db3474c8f8e6fc18bcd98d3
Autor:
Kangsan Kim, Madhusudhanan Narasimhan, Lenin Mahimainathan, Ray Zhang, Ellen Araj, Elizabeth Kim, William Tharpe, Benjamin M. Greenberg, David E. Greenberg, Quan-Zhen Li, Chi-An Cheng, Ravi Sarode, Srinivas Malladi, Alagarraju Muthukumar
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
BackgroundImmunocompromised (IC) patients show diminished immune response to COVID-19 mRNA vaccines (Co-mV). To date, there is no ‘empirical’ evidence to link the perturbation of translation, a rate-limiting step for mRNA vaccine efficiency (VE),
Externí odkaz:
https://doaj.org/article/162270adb1e54bdebf1c56d03ddedba4
Autor:
Juan Manuel Carreño, Hala Alshammary, Gagandeep Singh, Ariel Raskin, Fatima Amanat, Angela Amoako, Ana Silvia Gonzalez-Reiche, Adriana van de Guchte, PARIS study group, Komal Srivastava, Emilia Mia Sordillo, D. Noah Sather, Harm van Bakel, Florian Krammer, Viviana Simon
Publikováno v:
EBioMedicine, Vol 73, Iss , Pp 103626- (2021)
Background: Highly efficacious vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been developed. However, the emergence of viral variants that are more infectious than the earlier SARS-CoV-2 strains is concerning. Sev
Externí odkaz:
https://doaj.org/article/fab401c41070495fad05e747924fb0a0
Autor:
Pei‐Yee Onn, Catherina L. Chang
Publikováno v:
Respirology Case Reports, Vol 9, Iss 11, Pp n/a-n/a (2021)
Abstract The global effects of coronavirus disease 2019 (COVID‐19) have driven unprecedented rapid development and mass deployment of vaccinations against the novel coronavirus. However, the short‐ and long‐term adverse reactions following COVI
Externí odkaz:
https://doaj.org/article/db261f590e034c739e6fef4956563e4e